Vaxart Completes Enrollment Of The Sentinel Cohort In Its Phase 2b Study Of Its COVID-19 Oral Pill Vaccine Candidate
Vaxart Completes Enrollment Of The Sentinel Cohort In Its Phase 2b Study Of Its COVID-19 Oral Pill Vaccine Candidate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.